Magenta Therapeutics Stock Price, News & Analysis
Company Description
Magenta Therapeutics (Nasdaq: mgta) is a publicly traded company. The company has a market capitalization of $42.4M.
mgta stock has declined 100.0% over the past year.
This page provides a comprehensive overview of mgta stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Magenta Therapeutics (mgta) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $42.4M, mgta is classified as a micro-cap stock.
Latest News
Magenta Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, clinical trial, conferences, earnings. View all mgta news →